Torrey Growth & Income Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.34M Buy
5,248
+1
+0% +$1.02K 2.15% 10
2026
Q1
$4.81M Hold
5,247
2.02% 10
2025
Q4
$5.64M Buy
5,247
+30
+0.6% +$28.7K 1.96% 10
2025
Q3
$3.98M Buy
+5,217
New +$3.88M 1.17% 18

Other funds holding LLY

Torrey Growth & Income Advisors's LLY Position: Q2 2026 in Review

Torrey Growth & Income Advisors increased its Eli Lilly (LLY) stake by 0.02% in Q2 2026, buying an estimated $1.02K and bringing the position to 5,248 shares worth $6.34M. The position accounts for 2.15% of the portfolio, ranked #10.

Torrey Growth & Income Advisors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Torrey Growth & Income Advisors held 5,248 shares of Eli Lilly worth $6.34M as of Q2 2026.
  • Torrey Growth & Income Advisors bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 2.15% of Torrey Growth & Income Advisors's portfolio in Q2 2026, its #10 holding.
  • Torrey Growth & Income Advisors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.